semaglutide 7.2 mg clinical trial Once-weekly 7·2 in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b Wegovy HD 7.2mg Now Available
Description
Reduced Hyperactivity : It can help decrease excessive movements and restlessness

Slowly tapering the GLP-1 medication after reaching the higher dose to maintain the effects

it's about finding the optimal low dose of Semaglutide for your unique body

This foundation helps your healthcare team assess whether you're a candidate for standard weekly dosing, whether dose optimization is needed, or whether your profile suggests exploring compounded formulations or alternative GLP-1 options available through PlexusDx at $179$229 monthly
